Extended use of a percutaneous left-ventricular assist device without a heparin-based purge solution
- Therapy of unstable angina with the low molecular weight heparins. Ageno, W.; Turpie, A.G. // Vascular Medicine;2000, Vol. 5 Issue 4, p217
Unstable angina is in most cases caused by partial or complete coronary artery occlusion due to the disruption of an atherosclerotic plaque and to thrombus formation. An immediate antithrombotic approach is essential to prevent fatal and non-fatal myocardial infarction, and the combination of...
- Treat unstable angina with short-term heparin and long-term aspirin. Leibovitch, Eric R. // Modern Medicine;Jan97, Vol. 65 Issue 1, p60
Presents an abstract of the study `Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina: A meta-analysis,' by A. Oler, M.A. Whooley et al published in the September 11, 1996 issue of the `Journal of the American Medical Association.'
- Implantable cardioverter defibrillators after acute myocardial infarction: Evidence suggests no overall survival benefit if inserted within 40 days. Liew, Reginald // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;12/4/2010, Vol. 341 Issue 7784, p1174
The author analyzes a study which further explained why early insertion of an implantable cardioverter defibrillator soon after acute myocardial infarction may not improve survival. He noted the observation of the study that recurrent myocardial infarction (MI) or cardiac rupture to death was...
- Low-molecular-weight heparins: Review of their role for unstable angina/non-Q-wave MI. Reinhard, Felicia // Formulary;Dec2000, Vol. 35 Issue 12, p970
Explores how the low-molecular-weight heparins' (LMWH) pharmacologic differences from unfractionated heparin (UFH) form the basis for their use in this setting. Enhanced anti-factor Xa:anti-factor IIa ratio of LMWH; Clinical efficacy trials of LMWH for unstable angina/non-Q-wave myocardial...
- Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in the Secondary Prevention of Acute Coronary Syndrome. Brosa, M.; Rubio-Terrés, C.; Farr, I.; Nadipelli, V.; Froufe, J. // PharmacoEconomics;2002, Vol. 20 Issue 14, p979
Background: The Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) and Thrombolysis in Myocardial Infarction (TIMI) 11B studies revealed that enoxaparin reduced the incidence of death, myocardial reinfarction and recurrent angina in patients with acute...
- Low-molecular-weight heparin is better than unfractionated heparin in unstable angina and... // Modern Medicine;Oct97, Vol. 65 Issue 10, p18
Highlights results of the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events trial. Evidence of the superiority of an alternative to standard heparin treatment for unstable angina or non-Q-wave myocardial infarction; Advantage of the size of enoxaparin's molecules.
- Battle of the clot busters. Rhein Jr., Reginald // BMJ: British Medical Journal (International Edition);5/12/90, Vol. 300 Issue 6734, p1223
Examines the treatments for patients having a heart attack in Italy. Effectiveness of plasminogen activator for heart attack; Introduction of thrombolytic treatment for myocardial infarction; Application of intravenous heparin with activase.
- Continuing low-weight heparin after MI reduces recurrent events. // Geriatrics;Oct96, Vol. 51 Issue 10, p56
Presents an abstract of a research, `Reduction of Reinfarction and Angina with Use of Low-Molecular-Weight Heparin Therapy After Streptokinase (and heparin) in Acute Myocardial Infarction,' by A. Glick, R. Kornowski, Y. Michowich et al, published in 1996 issue of `American Journal of Cardiology.'
- Heparin for acute MI is not necessarily the best course. // Modern Medicine;Jul98, Vol. 66 Issue 7, p29
Presents an abstract of the article `Use and Effectiveness of Intravenous Heparin Therapy for Treatment of Acute Myocardial Infarction in the Elderly,' by H. M. Krumholz, J. Hennen, et al from the `Journal of American College Cardiol' dated April 1998.